Clinical Trial Update: Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

Cadonilimab is being studied in Phase 1/2 trials for advanced non-small cell lung cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: NSCLC Stage IV, NSCLC Stage IIIB | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING